Click here to get full coverage on PRAx announces 2026-27 arts season; Pink Martini pianist to be next artist-in-residence - OSU Today

PRAx announces 2026-27 arts season; Pink Martini pianist to be next artist-in-residence  OSU Today

PRAx announces 2026-27 arts season; Pink Martini pianist to be next artist-in-residence - OSU Today

Click here to get full coverage on Praxis gives 21 new employees stock awards tied to hiring - Stock Titan

Praxis gives 21 new employees stock awards tied to hiring  Stock Titan

Praxis gives 21 new employees stock awards tied to hiring - Stock Titan

Click here to get full coverage on Assessing Praxis Precision Medicines (PRAX) Valuation After Volatile Trading And Strong Long Term Returns - Sahm

Assessing Praxis Precision Medicines (PRAX) Valuation After Volatile Trading And Strong Long Term Returns  Sahm

Assessing Praxis Precision Medicines (PRAX) Valuation After Volatile Trading And Strong Long Term Returns - Sahm

Click here to get full coverage on A Look At Praxis Precision Medicines (PRAX) Valuation After Strong Long Term Shareholder Returns - Yahoo Finance

A Look At Praxis Precision Medicines (PRAX) Valuation After Strong Long Term Shareholder Returns  Yahoo Finance

A Look At Praxis Precision Medicines (PRAX) Valuation After Strong Long Term Shareholder Returns - Yahoo Finance

Click here to get full coverage on Phillips 66 completes Lindsey Oil Refinery sale - BBC

Phillips 66 completes Lindsey Oil Refinery sale  BBC

Phillips 66 completes Lindsey Oil Refinery sale - BBC

Click here to get full coverage on Wolfe Research initiates coverage of Praxis Precision Medicines (PRAX) with outperform recommendation - MSN

Wolfe Research initiates coverage of Praxis Precision Medicines (PRAX) with outperform recommendation  MSN

Wolfe Research initiates coverage of Praxis Precision Medicines (PRAX) with outperform recommendation - MSN

Click here to get full coverage on Phillips 66 Limited completes acquisition of Lindsey Oil Refinery assets - BIC Magazine

Phillips 66 Limited completes acquisition of Lindsey Oil Refinery assets  BIC Magazine

Phillips 66 Limited completes acquisition of Lindsey Oil Refinery assets - BIC Magazine

Click here to get full coverage on Phillips 66 completes Prax Lindsey refinery asset acquisition - Investing.com

Phillips 66 completes Prax Lindsey refinery asset acquisition  Investing.com

Phillips 66 completes Prax Lindsey refinery asset acquisition - Investing.com

Click here to get full coverage on $PRAX stock is up 9% today. Here's what we see in our data. - Quiver Quantitative

$PRAX stock is up 9% today. Here's what we see in our data.  Quiver Quantitative

$PRAX stock is up 9% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Praxis maps out two investor events in May, starting with Q1 results - Stock Titan

Praxis maps out two investor events in May, starting with Q1 results  Stock Titan

Praxis maps out two investor events in May, starting with Q1 results - Stock Titan

Click here to get full coverage on Praxis (PRAX) Aligns Pay With Ulixacaltamide Progress Is Incentive Design Now a Key Edge? - Yahoo Finance

Praxis (PRAX) Aligns Pay With Ulixacaltamide Progress Is Incentive Design Now a Key Edge?  Yahoo Finance

Praxis (PRAX) Aligns Pay With Ulixacaltamide Progress Is Incentive Design Now a Key Edge? - Yahoo Finance

Click here to get full coverage on Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  The Manila Times

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Click here to get full coverage on How Investors May Respond To Praxis (PRAX) Securing Dual FDA Reviews For Key Neurology Drug Candidates - simplywall.st

How Investors May Respond To Praxis (PRAX) Securing Dual FDA Reviews For Key Neurology Drug Candidates  simplywall.st

How Investors May Respond To Praxis (PRAX) Securing Dual FDA Reviews For Key Neurology Drug Candidates - simplywall.st

Click here to get full coverage on Vanguard (NASDAQ: PRAX) reports 1.42M shares, 5.09% stake in Praxis - Stock Titan

Vanguard (NASDAQ: PRAX) reports 1.42M shares, 5.09% stake in Praxis  Stock Titan

Vanguard (NASDAQ: PRAX) reports 1.42M shares, 5.09% stake in Praxis - Stock Titan

Click here to get full coverage on Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide - Yahoo Finance

Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide  Yahoo Finance

Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide - Yahoo Finance

Click here to get full coverage on Praxis (NASDAQ: PRAX) details 2026 virtual meeting, director slate and Say-on-Pay - Stock Titan

Praxis (NASDAQ: PRAX) details 2026 virtual meeting, director slate and Say-on-Pay  Stock Titan

Praxis (NASDAQ: PRAX) details 2026 virtual meeting, director slate and Say-on-Pay - Stock Titan

Click here to get full coverage on Praxis Precision Medicines Inc. (PRAX): Rare Triple-Catalyst Setup in Neurology - Yahoo Finance

Praxis Precision Medicines Inc. (PRAX): Rare Triple-Catalyst Setup in Neurology  Yahoo Finance

Praxis Precision Medicines Inc. (PRAX): Rare Triple-Catalyst Setup in Neurology - Yahoo Finance

Click here to get full coverage on Praxis Precision Medicines (PRAX): One of the Best Upside Stocks - Yahoo Finance

Praxis Precision Medicines (PRAX): One of the Best Upside Stocks  Yahoo Finance

Praxis Precision Medicines (PRAX): One of the Best Upside Stocks - Yahoo Finance

Click here to get full coverage on (PRAX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

(PRAX) Price Dynamics and Execution-Aware Positioning  Stock Traders Daily

(PRAX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Click here to get full coverage on LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $567 - Moomoo

LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $567  Moomoo

LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $567 - Moomoo

Click here to get full coverage on Is Praxis Precision Medicines (PRAX) Pricing In Its 10x One Year Surge? - simplywall.st

Is Praxis Precision Medicines (PRAX) Pricing In Its 10x One Year Surge?  simplywall.st

Is Praxis Precision Medicines (PRAX) Pricing In Its 10x One Year Surge? - simplywall.st

Click here to get full coverage on 7 million Americans with essential tremor see a first positive Phase 3 program - Stock Titan

7 million Americans with essential tremor see a first positive Phase 3 program  Stock Titan

7 million Americans with essential tremor see a first positive Phase 3 program - Stock Titan

Click here to get full coverage on FDA accepts Praxis (PRAX) ulixacaltamide NDA for adult essential tremor - Stock Titan

FDA accepts Praxis (PRAX) ulixacaltamide NDA for adult essential tremor  Stock Titan

FDA accepts Praxis (PRAX) ulixacaltamide NDA for adult essential tremor - Stock Titan

Click here to get full coverage on Prax Lindsey Oil Refinery Closure: Timeline and Key Dates - Energy Voice

Prax Lindsey Oil Refinery Closure: Timeline and Key Dates  Energy Voice

Prax Lindsey Oil Refinery Closure: Timeline and Key Dates - Energy Voice

Click here to get full coverage on (PRAX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

(PRAX) as a Liquidity Pulse for Institutional Tactics  Stock Traders Daily

(PRAX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Click here to get full coverage on FDA starts Praxis review for essential tremor drug, decision due Jan. 2027 - Stock Titan

FDA starts Praxis review for essential tremor drug, decision due Jan. 2027  Stock Titan

FDA starts Praxis review for essential tremor drug, decision due Jan. 2027 - Stock Titan

Click here to get full coverage on Praxis Precision gets FDA review for lead asset (PRAX:NASDAQ) - Seeking Alpha

Praxis Precision gets FDA review for lead asset (PRAX:NASDAQ)  Seeking Alpha

Praxis Precision gets FDA review for lead asset (PRAX:NASDAQ) - Seeking Alpha

Click here to get full coverage on JonesTrading Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $441 - Moomoo

JonesTrading Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $441  Moomoo

JonesTrading Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $441 - Moomoo

Click here to get full coverage on Praxis Precision Medicines (PRAX) Gets a Buy from LifeSci Capital - The Globe and Mail

Praxis Precision Medicines (PRAX) Gets a Buy from LifeSci Capital  The Globe and Mail

Praxis Precision Medicines (PRAX) Gets a Buy from LifeSci Capital - The Globe and Mail

Click here to get full coverage on Praxis Ulixacaltamide Milestone Reframes Essential Tremor Opportunity And Valuation - simplywall.st

Praxis Ulixacaltamide Milestone Reframes Essential Tremor Opportunity And Valuation  simplywall.st

Praxis Ulixacaltamide Milestone Reframes Essential Tremor Opportunity And Valuation - simplywall.st

Click here to get full coverage on $PRAX ($PRAX) Releases Q4 2025 Earnings - Quiver Quantitative

$PRAX ($PRAX) Releases Q4 2025 Earnings  Quiver Quantitative

$PRAX ($PRAX) Releases Q4 2025 Earnings - Quiver Quantitative

Click here to get full coverage on Is Praxis Precision Medicines (PRAX) Still Attractive After Its Big Share Price Run? - Yahoo Finance

Is Praxis Precision Medicines (PRAX) Still Attractive After Its Big Share Price Run?  Yahoo Finance

Is Praxis Precision Medicines (PRAX) Still Attractive After Its Big Share Price Run? - Yahoo Finance

Click here to get full coverage on A Look At Praxis Precision Medicines (PRAX) Valuation After FDA Priority Review For Relutrigine - Yahoo Finance

A Look At Praxis Precision Medicines (PRAX) Valuation After FDA Priority Review For Relutrigine  Yahoo Finance

A Look At Praxis Precision Medicines (PRAX) Valuation After FDA Priority Review For Relutrigine - Yahoo Finance

Click here to get full coverage on Why Is Praxis Precision Stock Soaring Tuesday? - Benzinga

Why Is Praxis Precision Stock Soaring Tuesday?  Benzinga

Why Is Praxis Precision Stock Soaring Tuesday? - Benzinga

Click here to get full coverage on A Look At Praxis Precision Medicines (PRAX) Valuation After Positive Elsunersen Seizure Reduction Data - simplywall.st

A Look At Praxis Precision Medicines (PRAX) Valuation After Positive Elsunersen Seizure Reduction Data  simplywall.st

A Look At Praxis Precision Medicines (PRAX) Valuation After Positive Elsunersen Seizure Reduction Data - simplywall.st

Click here to get full coverage on How Investors Are Reacting To Praxis (PRAX) Advancing Breakthrough NDA Plans With a 2028 Cash Runway - Yahoo Finance

How Investors Are Reacting To Praxis (PRAX) Advancing Breakthrough NDA Plans With a 2028 Cash Runway  Yahoo Finance

How Investors Are Reacting To Praxis (PRAX) Advancing Breakthrough NDA Plans With a 2028 Cash Runway - Yahoo Finance

Click here to get full coverage on PRAX (Praxis Precision Medicines Inc.) shares rise nearly 7 percent despite wider than expected Q4 2025 per share loss. - Stability Report - Cổng thông tin điện tử Tỉnh Sơn La

PRAX (Praxis Precision Medicines Inc.) shares rise nearly 7 percent despite wider than expected Q4 2025 per share loss. - Stability Report  Cổng thông tin điện tử Tỉnh Sơn La

PRAX (Praxis Precision Medicines Inc.) shares rise nearly 7 percent despite wider than expected Q4 2025 per share loss. - Stability Report - Cổng thông tin điện tử Tỉnh Sơn La

Click here to get full coverage on A Look At Praxis Precision Medicines (PRAX) Valuation As Analysts Reaffirm Bullish CNS Pipeline Views - Yahoo Finance

A Look At Praxis Precision Medicines (PRAX) Valuation As Analysts Reaffirm Bullish CNS Pipeline Views  Yahoo Finance

A Look At Praxis Precision Medicines (PRAX) Valuation As Analysts Reaffirm Bullish CNS Pipeline Views - Yahoo Finance

Click here to get full coverage on Union's concerns over refinery workers' new jobs - BBC

Union's concerns over refinery workers' new jobs  BBC

Union's concerns over refinery workers' new jobs - BBC

Click here to get full coverage on In a nine-patient Praxis trial, children had 77% fewer seizures - Stock Titan

In a nine-patient Praxis trial, children had 77% fewer seizures  Stock Titan

In a nine-patient Praxis trial, children had 77% fewer seizures - Stock Titan

Click here to get full coverage on Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX) - Yahoo Finance

Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX)  Yahoo Finance

Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX) - Yahoo Finance

Click here to get full coverage on More workers at oil refinery to lose their jobs - BBC

More workers at oil refinery to lose their jobs  BBC

More workers at oil refinery to lose their jobs - BBC

Click here to get full coverage on Is It Too Late To Reassess Praxis Precision Medicines (PRAX) After Its 1-Year Surge? - Yahoo Finance

Is It Too Late To Reassess Praxis Precision Medicines (PRAX) After Its 1-Year Surge?  Yahoo Finance

Is It Too Late To Reassess Praxis Precision Medicines (PRAX) After Its 1-Year Surge? - Yahoo Finance

Click here to get full coverage on Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800 - Yahoo Finance

Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800  Yahoo Finance

Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800 - Yahoo Finance

Click here to get full coverage on Wells Fargo Cautious on Praxis Precision (PRAX) After Recent Revenue Estimates - Yahoo Finance

Wells Fargo Cautious on Praxis Precision (PRAX) After Recent Revenue Estimates  Yahoo Finance

Wells Fargo Cautious on Praxis Precision (PRAX) After Recent Revenue Estimates - Yahoo Finance

Click here to get full coverage on Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus - Yahoo Finance

Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus  Yahoo Finance

Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus - Yahoo Finance

Click here to get full coverage on Praxis Precision Medicines (PRAX) Reports $926M 2025 Cash Balance, Extended Runway - Yahoo Finance

Praxis Precision Medicines (PRAX) Reports $926M 2025 Cash Balance, Extended Runway  Yahoo Finance

Praxis Precision Medicines (PRAX) Reports $926M 2025 Cash Balance, Extended Runway - Yahoo Finance

Click here to get full coverage on Prax Lindsey oil refinery bought out of administration by US rival - The Guardian

Prax Lindsey oil refinery bought out of administration by US rival  The Guardian

Prax Lindsey oil refinery bought out of administration by US rival - The Guardian

Click here to get full coverage on Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference - The Manila Times

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference  The Manila Times

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference - The Manila Times

Click here to get full coverage on Phillips 66 completes Prax Lindsey refinery asset acquisition By Investing.com - Investing.com UK

Phillips 66 completes Prax Lindsey refinery asset acquisition By Investing.com  Investing.com UK

Phillips 66 completes Prax Lindsey refinery asset acquisition By Investing.com - Investing.com UK

Click here to get full coverage on FDA fast-tracks Praxis drug for rare childhood epilepsy disorders - Stock Titan

FDA fast-tracks Praxis drug for rare childhood epilepsy disorders  Stock Titan

FDA fast-tracks Praxis drug for rare childhood epilepsy disorders - Stock Titan

Click here to get full coverage on Praxis Precision Medicines (PRAX): Reassessing Valuation After EMBOLD Success and Ulixacaltamide Pre-NDA Milestone - Yahoo Finance

Praxis Precision Medicines (PRAX): Reassessing Valuation After EMBOLD Success and Ulixacaltamide Pre-NDA Milestone  Yahoo Finance

Praxis Precision Medicines (PRAX): Reassessing Valuation After EMBOLD Success and Ulixacaltamide Pre-NDA Milestone - Yahoo Finance

Click here to get full coverage on On MLK Day, Kings Return at The PRAx - The Corvallis Advocate

On MLK Day, Kings Return at The PRAx  The Corvallis Advocate

On MLK Day, Kings Return at The PRAx - The Corvallis Advocate

Click here to get full coverage on Praxis: Strong Buy As Relutrigine Submission Accepted Plus Expansion Potential (PRAX) - Seeking Alpha

Praxis: Strong Buy As Relutrigine Submission Accepted Plus Expansion Potential (PRAX)  Seeking Alpha

Praxis: Strong Buy As Relutrigine Submission Accepted Plus Expansion Potential (PRAX) - Seeking Alpha

Click here to get full coverage on Eastview's Zach Prax recognized with NFHS Award for Speech and Debate - Minnesota State High School League

Eastview's Zach Prax recognized with NFHS Award for Speech and Debate  Minnesota State High School League

Eastview's Zach Prax recognized with NFHS Award for Speech and Debate - Minnesota State High School League

Click here to get full coverage on PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know - Yahoo Finance

PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know  Yahoo Finance

PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know - Yahoo Finance

Click here to get full coverage on Needham Analyst Keeps a Buy Rating on Praxis Precision Medicines, Inc. (PRAX) - Yahoo Finance

Needham Analyst Keeps a Buy Rating on Praxis Precision Medicines, Inc. (PRAX)  Yahoo Finance

Needham Analyst Keeps a Buy Rating on Praxis Precision Medicines, Inc. (PRAX) - Yahoo Finance

Click here to get full coverage on $PRAX stock is up 27% today. Here's what we see in our data. - Quiver Quantitative

$PRAX stock is up 27% today. Here's what we see in our data.  Quiver Quantitative

$PRAX stock is up 27% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Praxis lines up 4 brain drugs with $20B revenue potential - Stock Titan

Praxis lines up 4 brain drugs with $20B revenue potential  Stock Titan

Praxis lines up 4 brain drugs with $20B revenue potential - Stock Titan

Click here to get full coverage on Two new brain disorder drugs head to FDA as Praxis nears key 2026 data - Stock Titan

Two new brain disorder drugs head to FDA as Praxis nears key 2026 data  Stock Titan

Two new brain disorder drugs head to FDA as Praxis nears key 2026 data - Stock Titan

Click here to get full coverage on Biotech Praxis hands 2,964 stock units to eight new hires - Stock Titan

Biotech Praxis hands 2,964 stock units to eight new hires  Stock Titan

Biotech Praxis hands 2,964 stock units to eight new hires - Stock Titan

Click here to get full coverage on Prax oil tycoon gets approval to sell multimillion-pound mansion - The Times

Prax oil tycoon gets approval to sell multimillion-pound mansion  The Times

Prax oil tycoon gets approval to sell multimillion-pound mansion - The Times

Click here to get full coverage on PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know - Zacks Investment Research

PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know  Zacks Investment Research

PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know - Zacks Investment Research

Click here to get full coverage on Vanguard subsidiaries disaggregate holdings; Praxis (PRAX) shows 0 shares reported - Stock Titan

Vanguard subsidiaries disaggregate holdings; Praxis (PRAX) shows 0 shares reported  Stock Titan

Vanguard subsidiaries disaggregate holdings; Praxis (PRAX) shows 0 shares reported - Stock Titan

Click here to get full coverage on Praxis (PRAX) Stock Modified Order (Momentum Fading) 2026-04-16 - Viral Momentum Stocks - Cổng thông tin điện tử tỉnh Tây Ninh

Praxis (PRAX) Stock Modified Order (Momentum Fading) 2026-04-16 - Viral Momentum Stocks  Cổng thông tin điện tử tỉnh Tây Ninh

Praxis (PRAX) Stock Modified Order (Momentum Fading) 2026-04-16 - Viral Momentum Stocks - Cổng thông tin điện tử tỉnh Tây Ninh

Click here to get full coverage on “The best possible outcome” - Phillips 66 completes deal for Lindsey Oil Refinery assets - Insider Media Ltd

“The best possible outcome” - Phillips 66 completes deal for Lindsey Oil Refinery assets  Insider Media Ltd

“The best possible outcome” - Phillips 66 completes deal for Lindsey Oil Refinery assets - Insider Media Ltd

Click here to get full coverage on Praxis Precision Medicines, Inc. (PRAX) Gains Analyst Confidence With Ulixacaltamide - Finviz

Praxis Precision Medicines, Inc. (PRAX) Gains Analyst Confidence With Ulixacaltamide  Finviz

PRAX

Price Chart

Key Statistics

Technicals

About PRAX

Latest News

PRAx announces 2026-27 arts season; Pink Martini pianist to be next artist-in-residence - OSU Today

Praxis gives 21 new employees stock awards tied to hiring - Stock Titan

Assessing Praxis Precision Medicines (PRAX) Valuation After Volatile Trading And Strong Long Term Returns - Sahm

Advanced Charts

Top Gainers

Top Losers